C

Cogent Biosciences

146 employees

Cogent Biosciences is a biotechnology company that develops therapies for solid cancer tumors.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
gastrointestinal stromal tumors (GIST)
Health Care
kinase inhibitors
Therapeutics
Systemic Mastocytosis
Oncology
Medical

Date founded

2014

Funding rounds raised

Total raised

$104M

from 20 investors over 20 rounds

C

Cogent Biosciences raised $104M on July 6, 2020

Investors: Logos Global Management, LP, Atlas Venture, Commodore Capital, LP, Perceptive Advisors, RTW Investments, LP, OrbiMed Advisors and Samsara BioCapital

C

Cogent Biosciences raised $15M on March 15, 2017

Investors: Square 1 Bank

C

Cogent Biosciences raised $65M on June 11, 2015

Investors: Jennison Associates LLC, Sectoral Asset Management, Sanofi Ventures, Novo Holdings, Wellington Management, F-Prime Capital Partners, Seagen, Cowen Inc. and New Leaf Venture Partners

C

Cogent Biosciences raised $12M on October 21, 2014

Investors: Sanofi Ventures, F-Prime Capital Partners and Atlas Venture

FAQ